# A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

> **NCT07276958** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 63 (estimated)

## Conditions studied

- Healthy
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis

## Interventions

- **DRUG:** LY4298445
- **DRUG:** LY4298445

## Key facts

- **NCT ID:** NCT07276958
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276958, "A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07276958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*